StockData
Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc. (SGMT) stock

SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$9.85−0.28 (-2.76%)

Close on Nov 17, 2026Market cap $612.26MP/E –Yield –

Sagimet Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Sagimet Biosciences's enterprise value was $172.17M on Nov 11, 2026, against $107.62M a year earlier. Over the last 2 years it ranged from -$56.50M to $172.17M, with a median of $100.28M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$172.17M+162.3%
2025Dec 31, 2025$65.64M–
2023Oct 31, 2023-$17.73M–

More Sagimet Biosciences figures

See a number that looks wrong?